Jolanta Dorszewska

Editor, Professor Jolanta Dorszewska is Chief of Laboratory of Neurobiology, Department of Neurology, Poznan University of Medical Sciences (PUMS), Poznan, Poland. Prof. Dorszewska graduated from PUMS, (M.Sc., Pharmacy, 1987), Ph.D. degree obtained at PUMS, (1996), D.Sc. in Medical Sciences at PUMS, (2004) and Full Prof., (2016). Between the years 1999 and 2000 she worked as a Research Scientist at the Institute for Basic Research in Developmental Disabilities, New York, USA. Prof. Dorszewska is an author and co-author of about 100 papers (e.g. Oncotarget, Curr. Alzheimer Res., Seizure) mainly concerning the pathophysiology of Parkinson’s and Alzheimer’s diseases as well as epilepsy and migraine. She is also a co-author and co-editor of books on genetic and biochemical factors in neurological diseases. Prof. Dorszewska was also a Guest Editor of two Theme Issue in Current Genomics (2014, 2013), and a member of Editorial Board in Advances in Alzheimer’s Disease and Austin Alzheimer’s and Parkinson’s Disease (USA). Prof. Dorszewska is a member of the Commission of Neurochemistry of Neurological Sciences, Polish Academy of Science and Polish Association of Neuropathologists, as well as International Association of Neuropathologists.

3books edited

9chapters authored

Latest work with IntechOpen by Jolanta Dorszewska

Parkinson's disease is a common neurological disease and affects 2% population of more than 65 years of age and 5% more than 85 years of age. Pathomechanism of this disease is still not fully understood. This book is a sum up of knowledge on the genetic factors and neuronal death mechanisms induced by excitotoxic and inflammatory agents. The authors summarize the pathophysiology observed both in patients with Parkinson's disease and in experimental models. The book also contains the latest views on drug therapy used in the treatment of parkinsonism and other therapeutic approaches for Parkinson's disease. The book ''Challenges in Parkinson's Disease'' was made as a compendium on contemporary challenges in Parkinson's disease.

Go to the book